New Japan Chemical (4406) · FactFirst stated

Transfer of the equity interest in Nice Rika Biotechnologies Sdn. Bhd.

First written in FY2026. . Latest entry: FY2026.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Exclusion from Equity-Method Accounting Due to Sale of Shares in an Associate (Transfer Scope Unclear)A theme 18 companies write about · 0 as a headwind · 2 as a tailwind

4 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 18 companies compared. The sentences above are computed from all 18.

Full recordFilings, disclosures and news, newest first

FY2026First statedAnnual report
「Nice Rika Biotechnologies Sdn. Bhd. was excluded from the scope of application of the equity method from the current consolidated fiscal year because its equity interest was transferred.」
Nice Rika Biotechnologies Sdn. Bhd. was excluded from the scope of application of the equity method from the current consolidated fiscal year as a result of the transfer of its equity interest.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

New Japan Chemical's next results are scheduled for 2026-11-13. Read the earnings preview

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.